Heparin Sodium and 0.9% Sodium Chloride Injection (2020-01-31)
In plain language
This recall involves Heparin Sodium and 0.9% Sodium Chloride Injection sold in Canada. It's being recalled because an affected lot was inadvertently distributed to the market. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number W9J03B1.
- Return it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Heparin Sodium and 0.9% Sodium Chloride Injection
Lot: W9J03B1
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: W9J03B1
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Heparin Sodium and 0.9% Sodium Chloride Injection sold in Canada. It's being recalled because an affected lot was inadvertently distributed to the market. Stop using the product and follow the return steps in the official notice.
What should consumers do?
Stop using the product immediately. Check the lot number W9J03B1. Return it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on January 31, 2020.